A Study About Low Blood Pressure in Patients With Primary Immunodeficiency Disease Treated With Immune Globulin Products

UnknownOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

December 31, 2022

Study Completion Date

June 30, 2023

Conditions
Primary Immune Deficiency Disorder
Interventions
BIOLOGICAL

Bivigam

Human immune globulin

BIOLOGICAL

Other

Human immune globulin

Trial Locations (17)

11234

The Center for Allergy, Asthma & Immunology, Syosset

22030

Lysosomal Rare Disorders Research & Treatment Center, Fairfax

28204

Allergy Asthma & Immunology Relief, Charlotte

31201

Central Georgia Infectious Disease Consultants, Macon

44124

Ohio Clinical Research Associates, Mayfield Heights

61761

Midwest Allergy and Sinus, Normal

66211

Kanarek Adult & Pediatric Allergy & Immunology, Overland Park

67211

Infectious Disease Consultants, Wichita

73131

Oklahoma Institute of Allergy and Asthma Clinical Research, Oklahoma City

75225

Discovery Clinical Trials, Dallas

75230

Allergy Partners of North Texas, Dallas

75231

Allergy Immunology and Respiratory Care, Dallas

75390

University of Texas Southwestern Medical Center, Irving

78705

Austin Infectious Disease Consultants, Austin

80112

Immunoe Research Centers, Centennial

93013

Santa Barbara Specialty Pharmacy, Carpinteria

94598

Allergy and Asthma of the Bay Area, Walnut Creek

Sponsors
All Listed Sponsors
lead

ADMA Biologics, Inc.

INDUSTRY